Skip to main content

Overuse Injury

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Linnaeus Therapeutics
Linnaeus TherapeuticsNJ - Haddonfield
1 program
Sustainable Elite FootballN/A1 trial
Active Trials
NCT07325084Enrolling By Invitation400Est. Dec 2032
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Throwing DeviceN/A1 trial
Active Trials
NCT04098107Completed10Est. Jun 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Linnaeus TherapeuticsSustainable Elite Football
Human BioSciencesThrowing Device

Clinical Trials (2)

Total enrollment: 410 patients across 2 trials

NCT07325084Linnaeus TherapeuticsSustainable Elite Football

Sustainable Elite Football

Start: Nov 2024Est. completion: Dec 2032400 patients
N/AEnrolling By Invitation

Throwing Device Tracker for Youth Injury Prevention

Start: Jun 2019Est. completion: Jun 202210 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.